The Quotes are Powered By Forexpros, the Forex, Futures, and Stock Markets Portal.

Companies News

Meda's acquisition of Acton Pharmaceuticals completed

Monday, 21 October 2013
On August 30th, 2013, Meda announced the acquisition of Acton Pharmaceuticals, Inc. and its proprietary product Aerospan. The company can now announce that the acquisition has now been completed.

The purchase price for Acton amounted to 135 MUSD, on a cash and debt free basis. In addition, there is a milestone payment of 10 million USD and royalty based milestones. About Aerospan Aerospan

Aerospan (flunisolide HFA, 80 mcg) is approved by the U.S. Food and Drug Administration (“FDA”) for the treatment of asthma in adult and paediatric patients 6 years of age and older. Aerospan is the first and only product registered in the US market with a built-in inhalation chamber (called a “spacer”) which assists in the delivery of the medicine to the lungs.

Print Friendly and PDF

Did you spot any error(s) or had any problem with the above article. Please contact us